To answer SandraNC_45's question specifically:

From a clinical standpoint, Singapore HSA regulations 12 is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

+1. This mirrors my journey exactly. The Singapore HSA discussion here is so valuable.

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Singapore HSA regulations.

To answer quinn_sf: I started tracking everything in a spreadsheet from day 1.

Quick update: I will post a proper update thread soon. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Subscribing to this thread. Singapore HSA regulations is exactly what I've been researching. 🙏

+1 to DanielChem_CHI. Especially the point about "Singapore HSA regulations 12 month is n..." — I have seen the same in my own experience with Singapore HSA regulations.